DAX
18.726,76 -42,20 (-0,22%) Euro Stoxx 50
5.046,99 -27,35 (-0,54%) Dow Jones 30
39.810,03 +3,26 (+0,01%) Gold
2.426,40 -12,10 (-0,50%) EUR/USD
1,0853 -0,0008 (-0,08%) Bitcoin EUR
64.149,11 +1.076,83 (+1,71%)
Die meistgehandelten Penny-Aktien
61,11k Follower • 31 Symbole Watchlist von Yahoo Finance
Folgen Sie dieser Liste, um Penny-Aktien mit dem höchsten Tagesvolumen zu entdecken und zu verfolgen.
Zusammengestellt von Yahoo Finance
Folgen Sie dieser Liste, um Penny-Aktien mit dem höchsten Tagesvolumen zu entdecken und zu verfolgen.
Die Liste enthält Aktien mit einem Preis von 5 $ oder weniger und einer Tagesveränderung von mehr als 3 %. Diese Liste wird täglich erstellt und nach Marktkapitalisierung sortiert. Die Gewinne basieren auf dem letzten Schlusskurs und sind auf die Top-30-Aktien beschränkt, welche die Kriterien erfüllen.
Hintergrund
Yahoo Finanzen verwendet ausgefeilte Algorithmen, um Trends in den globalen Finanzmärkten zu überwachen und zu erkennen. Wir stellen Ihnen diese Einblicke in Form von Watchlists zur Verfügung.
Finden Sie andere überzeugende Anlageideen mit dem Yahoo Finanzen-Screener.
Wie werden diese gewichtet?Die Aktien in dieser Watchlist sind gleich gewichtet.
Performance
| Watchlist | Änderung heute | Monatlicher Ertrag | Jährlicher Ertrag | Gesamtertrag |
|---|---|---|---|---|
| Die meistgehandelten Penny-Aktien | +49.75% | - | - | - |
| ^GSPC | - | - | - | - |
31 Symbole
| Symbol | Firmenname | Letzter Preis | Änderung | % Schwankung | Marktzeit | Volumen | Durchschn. Vol. (3 Monate) | Marktkap. |
|---|---|---|---|---|---|---|---|---|
| NKLA | Nikola Corporation | 0.5422 | +0.02 | +2.89% | 13:17 GMT-4 | 115,95M | 96,33M | 735,52M |
| FLJ | FLJ Group Limited | 1.14 | +0.36 | +46.72% | 13:17 GMT-4 | 25,94M | 1,11M | 378,47M |
| CTXR | Citius Pharmaceuticals, Inc. | 0.7418 | +0.08 | +12.41% | 13:17 GMT-4 | 18,45M | 983,83k | 134,02M |
| BNED | Barnes & Noble Education, Inc. | 0.6333 | +0.32 | +104.29% | 13:17 GMT-4 | 106,17M | 3,41M | 33,66M |
| DPLS | DarkPulse, Inc. | 0.00274 | +0.00 | +37.00% | 13:02 GMT-4 | 119,48M | 12,92M | 21,74M |
| MMAT | Meta Materials Inc. | 3.22 | +0.92 | +40.00% | 13:17 GMT-4 | 37,81M | 370,45k | 21,56M |
| MGRX | Mangoceuticals, Inc. | 0.6499 | +0.40 | +165.24% | 13:17 GMT-4 | 215,27M | 570,38k | 16,13M |
| MGOL | MGO Global, Inc. | 0.92 | +0.69 | +302.27% | 13:17 GMT-4 | 261,01M | 232,98k | 15,09M |
| AULT | Ault Alliance, Inc. | 0.4399 | +0.05 | +12.10% | 13:17 GMT-4 | 45,03M | 6,36M | 13,23M |
| BDRX | Biodexa Pharmaceuticals Plc | 2.375 | +1.10 | +87.01% | 13:17 GMT-4 | 111,05M | 2,96M | 10,41M |
| BLEG | Branded Legacy Inc | 0.0034 | +0.00 | +25.93% | 12:44 GMT-4 | 46,28M | 11,52M | 10,05M |
| BRNE | Borneo Resource Investments Ltd. | 0.0009 | +0.00 | +28.57% | 12:45 GMT-4 | 34,88M | 887,14k | 9,45M |
| PLPL | Plandaí Biotechnology, Inc. | 0.0006 | +0.00 | +50.00% | 13:02 GMT-4 | 414,24M | 78,54M | 5,33M |
| WDLF | Decentral Life, Inc. | 0.00065 | +0.00 | +30.00% | 12:49 GMT-4 | 21,15M | 7,96M | 4,81M |
| AGRI | AgriFORCE Growing Systems Ltd. | 0.1458 | +0.02 | +13.37% | 13:17 GMT-4 | 179,67M | 4,59M | 3,80M |
| RONN | RONN Inc. | 0.0093 | -0.00 | -23.14% | 13:02 GMT-4 | 137,53M | 36,02M | 3,27M |
| CRCW | The Crypto Company | 0.0018 | +0.00 | +20.00% | 12:59 GMT-4 | 29,97M | 25,60M | 1,93M |
| INND | InnerScope Hearing Technologies, Inc. | 0.0002 | +0.00 | +33.33% | 12:44 GMT-4 | 36,14M | 35,77M | 1,49M |
| CGAC | Code Green Apparel Corp. | 0.0003 | +0.00 | +50.00% | 11:51 GMT-4 | 40,98M | 47,94M | 1,29M |
| BLDV | Blue Diamond Ventures, Inc. | 0.00025 | +0.00 | +25.00% | 12:54 GMT-4 | 25,42M | 5,83M | 1,22M |
| CBIA | Canopus BioPharma Incorporated | 0.0004 | +0.00 | +60.00% | 13:01 GMT-4 | 644,31M | 101,73M | 1,12M |
| SPRV | Supurva Healthcare Group, Inc. | 0.00035 | +0.00 | +133.33% | 13:01 GMT-4 | 1,20B | 2,04M | 1,10M |
| GSAC | GelStat Corp. | 0.0006 | +0.00 | +100.00% | 13:01 GMT-4 | 100,71M | 5,77M | 1,05M |
| AAGC | All American Gold Corp. | 0.0005 | +0.00 | +11.11% | 12:48 GMT-4 | 41,78M | 4,21M | 878,39k |
| BDPT | BioAdaptives, Inc. | 0.0007 | +0.00 | +40.00% | 12:55 GMT-4 | 181,79M | 33,14M | 680,51k |
| PSYC | PSYC Corporation | 0.001 | +0.00 | +5.26% | 12:58 GMT-4 | 15,40M | 16,91M | 602,94k |
| GTVH | Golden Triangle Ventures, Inc. | 0.0013 | +0.00 | +85.71% | 13:01 GMT-4 | 433,17M | 31,30M | 528,21k |
| TKMO | Tekumo, Inc. | 0.0005 | +0.00 | +25.00% | 12:08 GMT-4 | 21,31M | 24,16M | 356,69k |
| VIZC | VizConnect, Inc. | 0.0004 | +0.00 | +14.29% | 11:35 GMT-4 | 15,41M | 16,00M | 296,57k |
| PPCB | Propanc Biopharma, Inc. | 0.0009 | +0.00 | +38.46% | 13:01 GMT-4 | 36,65M | 5,85M | 151,18k |
Barrons.comNikola Stock Has Tumbled. The CEO Just Bought a Million Shares.
Nikola President and CEO Steve Girsky paid $540,000 for a million shares of the embattled hydrogen-truck company.
GlobeNewswirePositive Statistically Significant Phase 2 Clinical Trial Results of Biodexa’s Newly-licensed eRapa™ in Familial Adenomatous Polyposis (FAP) Scheduled for Presentation at the 2024 Digestive Disease Week Annual Meeting
May 21, 2024 Biodexa Pharmaceuticals PLC(“Biodexa” or the “Company”) Positive Statistically Significant Phase 2 Clinical Trial Results of Biodexa’s Newly-licensed eRapa™ in Familial Adenomatous Polyposis (FAP) Scheduled for Presentation at the 2024 Digestive Disease Week Annual Meeting Overall 83% non-progression rate at 6 Months Statistically Significant decrease in overall mean polyp burden at 6 months (p=0.04) Biodexa Pharmaceuticals PLC, (Nasdaq: BDRX), an acquisition-focused clinical stage
GlobeNewswireMangoRx to Introduce Oral Semaglutide and Tirzepatide in Response to Increasing Patient Demand for GLP-1 Medications
Formulations to be marketed as “Slim” and “Trim” as an Oral Dissolvable Tablet (ODT) Dallas, TX, May 21, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“MangoRx” or the “Company”), a company focused on developing, marketing, and selling a variety of men’s health and wellness products in the area of erectile dysfunction (ED), hair growth and hormone replacement therapies is excited to announce the development of proprietary oral formulations of Semaglutide (“Slim”) and Tirzepatide
